If you are working in any of the following scientific/business topic areas, we encourage you to submit a proposal for a podium presentation. We are especially looking for case studies with new data on the following:

Antibody Engineering & Therapeutics Track

  • Emerging In Vitro Approaches to Antibody Discovery             
  • Advanced In Vivo Antibody Discovery            
  • Modulating the Fc Region of Antibodies
  • Multi-specific Engineering    
  • Co-stimulation and Cell Engagers    
  • Masked, Gated & Conditionally Activated Antibodies
  • Non-Oncology Novel Targets and Approaches          
  • AI & Machine Learning in Antibody Discovery and Development
  • Antibody Drug Conjugates – Novel Payloads and Engineering

Antibody-Drug Conjugates Track

  • Dual and Multi-Payload ADCs
  • Novel ADC Payload Classes
  • Improved Linker and Conjugation Technologies
  • ADCs for Novel Targets and Indications
  • ADC Combination Therapy Approaches
  • Bispecific ADCs
  • Tumor-Specific Release of Payloads
  • AOCs: Antibody-Oligonucleotide Conjugates
  • Pharmacology and Mechanism of ADCs: Metabolic Rate, Tumor Penetration
  • Conditional Binding and Masking Strategies for ADCs
  • ADC Clinical Updates

Submit Your Proposal

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.

You will be notified by the Event Review Committee if your presentation has been selected.

Call for Speakers

December 14 - 17, 2025
Marriott Marquis San Diego
San Diego, CA

27 - 29 May, 2026
Congress Center
Basel Switzerland

Terms and Conditions  |  Privacy Policy

† You may still receive emails from us regarding any current registrations or orders.